CompanyIntelligence | Abgenix, Inc.

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$38	Subscribers Preview	2000	Abgenix and CuraGen to Develop Up to 250 Antibody Therapeutic Candidates	Abgenix, Inc.	CuraGen Corp.
$37	Subscribers Preview	2003	CuraGen and Abgenix Announce Progress in Antibody Alliance and Sign New Agreement for Antibody Production	Abgenix, Inc.	CuraGen Corp.
$34	Subscribers Preview	2002	CuraGen and Abgenix Scientists Develop Fully Human Monoclonal Antibodies to PDGF D	Abgenix, Inc.	CuraGen Corp.
$41	Subscribers Preview	2004	CuraGen Reports Second Quarter 2004 Financial Results	Abgenix; CuraGen	Seattle Genetics
$41	Subscribers Preview	2003	CuraGen Reports Third Quarter 2003 Financial Results	Abgenix, Inc.	CuraGen Corp.
$36	Subscribers Preview	2004	For Immediate Release	Abgenix; Praecis	Schering
$32	Subscribers Preview	2004	For Immediate Release	Abgenix, Inc.
$36	Subscribers Preview	2004	For Immediate Release	Abgenix, Inc.
$39	Subscribers Preview	2004	For Immediate Release	Abgenix, Inc.
$32	Subscribers Preview	2004	For Immediate Release	Abgenix, Inc.
$34	Subscribers Preview	2003	For Immediate Release	Abgenix, Inc.
$37	Subscribers Preview	2003	For Immediate Release	Abgenix, Inc.	Human Genome Sciences Inc.
$37	Subscribers Preview	2003	For Immediate Release	Abgenix, Inc.
$34	Subscribers Preview	2002	For Immediate Release	Abgenix, Inc.
$59	Subscribers	2001	Form 13f-Hr	Abgenix; Cabot; CIGNA	EGL 2 3 4 5 6 2 3 4
$31	Subscribers	2000	News Release	Abgenix, Inc.
$37	Subscribers	2000	Press Release	Abgenix, Inc.	ImmunoGen, Inc.
$33	Subscribers Preview	2003	Press Release	Abgenix, Inc.	CuraGen Corp.
$32	Subscribers	2004	Press Release	Abgenix; Cardinal Health; Dendreon	Dyax; Genentech; Nuvelo
$38	Subscribers	2004	Press Release	Abgenix; Dendreon; Dyax	Genentech; Nuvelo